Selection Committee
Comprises domestic and international experts with extensive knowledge and experience in research and development of drugs, vaccines, and diagnostics. The Selection Committee is the key decision-making body in reviewing applications and awarding investments in this area. This committee evaluates investment proposals and reports from development partners, and recommends investments to the Board of Directors.
Chairman
Paul Herrling
Former Head of Corporate Research at Novartis and the Chairman of the Board of the Novartis Institute for Tropical Diseases
Member
Ann Mills-Duggan
Partner, Innovations, Wellcome Trust
Member
Melissa Malhame
Principal, MM Global Health Consulting LLC
Member
Insoo Kim
CEO/Founder, Eupidia Co., Ltd
Member
Christian Lienhardt
Research Director, French National Research Institute for Development (IRD, Institut de Recherche pour le Développement)
Member
Gerald Voss
Executive Director
SciPeo Sprl, Science and People
Ex-officio
Dan Wattendorf
Director of Innovative Technology Solutions, Bill and Melinda Gates Foundation
Member
Joon Haeng Rhee
Professor of Microbiology, Chonnam National University Medical School